The FY26 HHS Budget in Brief has been released. It outlines how the existing NIH institutes & centers will be combined into eight (with only NCI, NIA & NIAID retaining their original structure). There are 40% cuts proposed in NIH budget (including the NCI). 😢 Cancer Research 📉

Yes, this happened today! Stacey Bowers (Sr. Dir. Community Engagement) and Kate O'Donnell, PhD, USMC (LCRF Scientific Advisory Board Chair) representing LCRF at the Lung SPORE meeting at MD Anderson Cancer Center

Promoted ! 🙌

Congratulations to the 2025 Sabin Family Fellows — 10 early career researchers selected for their bold, high-impact cancer research. We thank the Sabin Family Fellowship for their continued support. spr.ly/60154Ibll #EndCancer

The power of a bipartisan America—that refuses to dismantle science, cares about patients, and understands that medical academic research is also an economic engine. Thank you to the senators who stood up for NIH and the future of American health. science.org/content/articl….

Thanks to Dr. Dannie Mara Sherman Lab Nik Joshi & Diana Hargreaves for organizing an amazing meeting ! #MechModels2025 Salk Institute

So proud of our superstar summer students Torii🌺 and Emmanuel O for their beautiful posters, presentations, and rotations. It was a joy to have you with us! MD Anderson Cancer Center

The September issue of Cancer Research is online, featuring two studies exploring the role of RIT1 in #LungCancer. Here are the back to back original articles: aacrjournals.org/cancerres/arti… aacrjournals.org/cancerres/arti… And accompanying editorial by Aria Vaishnavi, PhD aacrjournals.org/cancerres/arti…

Honored to receive the 2026 ASBMB Ruth Kirschstein Award for Maximizing Access in Science. Research Trainee Affairs at Penn Medicine Univ. of Pennsylvania Department of Cancer Biology.

The lung cancer community is rallying in support of D. Ross Camidge, MD, PhD, a renowned clinical oncologist and researcher at University of Colorado Cancer Center who has recently gone public with his own lung cancer diagnosis. news.cuanschutz.edu/cancer-center/… His determination,

Come learn more about macrophages from THE Jennifer Guerriero, PhD at her talk at the radiation research society in less than one hour!

Thrilled to see my former postdoc mentor, Anthony Letai MD PhD appointed as the new NCI Director — there is truly no one better for this position. A bold step toward advancing cancer science and patient impact. 🌟 #NCIDirector #CancerResearch #Leadership nih.gov/news-events/ne…

time.com/collections/ti… Susan Bullman you are my hero!! MD Anderson Cancer Center

Clonal hematopoiesis in solid tumors matters! I am so excited to share that my postdoctoral work studying the ways in which TET2-mutant macrophages can improve response to immune checkpoint therapy is out now at Cancer Cell! cell.com/cancer-cell/fu…

📢It’s now out in ⁦Nature Genetics⁩! 🎉Congratulations to our amazing team ⁦Yibo⁩ ⁦Michael Green, PhD⁩ and wonderful collaborators ⁦⁦MD Anderson Cancer Center⁩ #SpatialOmics #TME #inflammatory niches 🌟Data & Code are publicly available nature.com/articles/s4158…

Truly honored to have been recognized as the inaugural James P Allison Institute Catalyst Award recipient. So proud of our exceptional research community and what you have been able to achieve in pursuit of our goal: eliminating cancer.

Today is the first day of Lung Cancer Awareness Month. In the U.S. alone, 621 people PER DAY will receive a lung cancer diagnosis this year. All you need is lungs to get lung cancer. Spread the word 📣 - visit LCRF.org/LCAM for ways to help. #LCAM #LCSM

In this Cancerwise podcast episode, Leah Phillips and her doctor, Dr. Mara Antonoff, discuss her experience with getting a stage IV lung cancer diagnosis at 43 and why lung cancer should not be considered a smoker’s disease: mdanderson.org/podcast?segite… #EndCancer

Even though early detection of #LungCancer drastically improves outcomes, less than 20% of people who qualify for screening actually get it done. If you know someone who qualifies, urge them to talk to their doctor. LCRF.org/LCAM. #LCAM

#FDA granted accelerated approval for #sevabertinib for #HER2-mutant #NSCLC 🎂 🌺 🩷 📖 In previously treated patients without prior anti-HER2 targeted therapies (SOHO-01, cohort D) 👉 ORR 64% 👉 Duration of Response 9.2 months 👉 PFS 8.3 months 👉 most common side effect is